
Aarti
AARTIPHARM.NSAarti Pharmalabs Limited Price (AARTIPHARM.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
90,633,564
(0.0083)%Revenue and Profitability
Year | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenue | 0 | 0 | 11,935,153,000 | 19,452,300,000 | 18,155,052,000 |
Net Income | -186,751 | -45,960 | -771,378 | 1,934,934,000 | 2,169,020,000 |
FCF USD | -186,751 | 0 | -1,412,551,601 | 1,433,400,000 | 175,695,000 |
OCF USD | -186,751 | 0 | -1,031,601 | 2,630,000,000 | 2,163,546,000 |
Financial Health - DEBT
Year | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
YTPD | 0.00 | 0.00 | -27.05 | 0.00 | 0.08 |
D/E | 0.08 | 0.08 | 2,279.94 | 0.14 | 0.16 |
CA/CL | - | 54.40 | 18.55 | 1.95 | 1.94 |
TA/TL | 13.39 | 10.74 | 18.55 | 3.32 | 3.13 |
Total Debt | 186,751 | 186,751 | 3,410,587,000 | 2,144,900,000 | 2,852,540,000 |
Management Performance
Year | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
ROIC | -7.47% | 0.00% | -2.53% | 11.28% | 10.47% |
ROE | -8.07% | -2.03% | -51.57% | 12.42% | 12.34% |
ROA | 0.00% | -1.84% | -48.79% | 11.69% | 8.40% |
NM % | - | - | -0.01% | 9.95% | 11.95% |
FCF / R% | 0.00% | 0.00% | -11.84% | 7.37% | 0.97% |
FCF / NI% | 100.00% | 0.00% | 183,120.55% | 54.97% | 8.10% |
Operating Margin (OM) | - | - | 0.60 | 0.46 | 0.60 |
Per Share
Year | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EPS | -0.75 | -0.18 | -0.01 | 21.35 | 23.93 |
SPS | 0.00 | 0.00 | 131.70 | 214.64 | 200.30 |
OCPS | -0.75 | 0.00 | -0.01 | 29.02 | 23.87 |
FCPS | -0.75 | 0.00 | -15.59 | 15.82 | 1.94 |
BVPS | 9.29 | 9.07 | 0.02 | 171.97 | 193.85 |
Per Share - CAGR
Year | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAGR-EPS | -0.75 | -0.18 | -0.01 | 21.35 | 23.93 |
CAGR-SPS | 0.00 | 0.00 | 131.70 | 214.64 | 200.30 |
CAGR-OCPS | -0.75 | 0.00 | -0.01 | 29.02 | 23.87 |
CAGR-FCPS | -0.75 | 0.00 | -15.59 | 15.82 | 1.94 |
CAGR-BVPS | 9.29 | 9.07 | 0.02 | 171.97 | 193.85 |